250 related articles for article (PubMed ID: 16036026)
1. Inhibition of RAAS--when is it too much?
Navarro P; Moskowitz R; Le Jemtel TH
Curr Heart Fail Rep; 2004 Jul; 1(2):57-64. PubMed ID: 16036026
[TBL] [Abstract][Full Text] [Related]
2. Optimal antagonism of the Renin-Angiotensin-aldosterone system: do we need dual or triple therapy?
Werner C; Pöss J; Böhm M
Drugs; 2010 Jul; 70(10):1215-30. PubMed ID: 20568830
[TBL] [Abstract][Full Text] [Related]
3. [Role of RAAS inhibitors for the treatment of heart failure].
Murohara T
Nihon Rinsho; 2012 Sep; 70(9):1577-81. PubMed ID: 23012806
[TBL] [Abstract][Full Text] [Related]
4. The renin-angiotensin-aldosterone system and heart failure.
Sayer G; Bhat G
Cardiol Clin; 2014 Feb; 32(1):21-32, vii. PubMed ID: 24286576
[TBL] [Abstract][Full Text] [Related]
5. Renin-angiotensin-aldosterone system inhibitors in heart failure.
Shearer F; Lang CC; Struthers AD
Clin Pharmacol Ther; 2013 Oct; 94(4):459-67. PubMed ID: 23852393
[TBL] [Abstract][Full Text] [Related]
6. Renin-angiotensin-aldosterone system inhibition: overview of the therapeutic use of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, mineralocorticoid receptor antagonists, and direct renin inhibitors.
Mercier K; Smith H; Biederman J
Prim Care; 2014 Dec; 41(4):765-78. PubMed ID: 25439533
[TBL] [Abstract][Full Text] [Related]
7. Meta-Analysis Evaluating the Effects of Renin-Angiotensin-Aldosterone System Blockade on Outcomes of Heart Failure With Preserved Ejection Fraction.
Kuno T; Ueyama H; Fujisaki T; Briasouli A; Takagi H; Briasoulis A
Am J Cardiol; 2020 Apr; 125(8):1187-1193. PubMed ID: 32081366
[TBL] [Abstract][Full Text] [Related]
8. Blockade of the renin-angiotensin-aldosterone system (RAAS) for primary prevention of non-valvular atrial fibrillation: a systematic review and meta analysis of randomized controlled trials.
Khatib R; Joseph P; Briel M; Yusuf S; Healey J
Int J Cardiol; 2013 Apr; 165(1):17-24. PubMed ID: 22421406
[TBL] [Abstract][Full Text] [Related]
9. Cardiorenal protection during chronic renin-angiotensin-aldosterone system suppression: evidences and caveats.
Ruiz-Hurtado G; Ruilope LM
Eur Heart J Cardiovasc Pharmacother; 2015 Apr; 1(2):126-31. PubMed ID: 27533982
[TBL] [Abstract][Full Text] [Related]
10. Combination Therapy of Renin Angiotensin System Inhibitors and β-Blockers in Patients with Heart Failure.
Nochioka K; Sakata Y; Shimokawa H
Adv Exp Med Biol; 2018; 1067():17-30. PubMed ID: 29542073
[TBL] [Abstract][Full Text] [Related]
11. Sex differences in heart failure medications targeting the renin-angiotensin-aldosterone system.
Nicolaou PA
Eur J Pharmacol; 2021 Apr; 897():173961. PubMed ID: 33617824
[TBL] [Abstract][Full Text] [Related]
12. Renin-angiotensin-aldosterone system (RAAS) pharmacogenomics: implications in heart failure management.
Beitelshees AL; Zineh I
Heart Fail Rev; 2010 May; 15(3):209-17. PubMed ID: 18351457
[TBL] [Abstract][Full Text] [Related]
13. Renin-angiotensin-aldosterone system blockers for heart failure with reduced ejection fraction or left ventricular dysfunction: Network meta-analysis.
Xie W; Zheng F; Song X; Zhong B; Yan L
Int J Cardiol; 2016 Feb; 205():65-71. PubMed ID: 26720043
[TBL] [Abstract][Full Text] [Related]
14. The past, present and future of renin-angiotensin aldosterone system inhibition.
Mentz RJ; Bakris GL; Waeber B; McMurray JJ; Gheorghiade M; Ruilope LM; Maggioni AP; Swedberg K; Piña IL; Fiuzat M; O'Connor CM; Zannad F; Pitt B
Int J Cardiol; 2013 Sep; 167(5):1677-87. PubMed ID: 23121914
[TBL] [Abstract][Full Text] [Related]
15. Pathophysiologic role of the renin-angiotensin-aldosterone and sympathetic nervous systems in heart failure.
Adams KF
Am J Health Syst Pharm; 2004 May; 61 Suppl 2():S4-13. PubMed ID: 15160833
[TBL] [Abstract][Full Text] [Related]
16. Does blockade of the Renin-Angiotensin-aldosterone system slow progression of all forms of kidney disease?
Lattanzio MR; Weir MR
Curr Hypertens Rep; 2010 Oct; 12(5):369-77. PubMed ID: 20703958
[TBL] [Abstract][Full Text] [Related]
17. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ
Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527
[No Abstract] [Full Text] [Related]
18. Novel blockers of the renin-angiotensin-aldosterone system in chronic heart failure.
Valluri A; Struthers AD; Lang CC
Curr Heart Fail Rep; 2014 Mar; 11(1):31-9. PubMed ID: 24234398
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of the renin-angiotensin-aldosterone system for cerebrorenal protection.
Lambers Heerspink HJ
Contrib Nephrol; 2013; 179():7-14. PubMed ID: 23652444
[TBL] [Abstract][Full Text] [Related]
20. Hypertension: renin-angiotensin-aldosterone system alterations.
Te Riet L; van Esch JH; Roks AJ; van den Meiracker AH; Danser AH
Circ Res; 2015 Mar; 116(6):960-75. PubMed ID: 25767283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
